Bal Pharma Limited (BOM:524824)
India · Delayed Price · Currency is INR 67.05
-1.45 (-2.12%)
At close: Jan 23, 2026
Bal Pharma Market Cap
Bal Pharma has a market cap or net worth of 1.09 billion as of January 23, 2026. Its market cap has decreased by -45.41% in one year.
Market Cap
1.09B
Enterprise Value
2.55B
Revenue
2.95B
Ranking
n/a
PE Ratio
15.96
Stock Price
67.05
Market Cap Chart
Since December 20, 2004, Bal Pharma's market cap has increased from 559.95M to 1.09B, an increase of 94.76%. That is a compound annual growth rate of 3.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 1.07B | -8.46% |
| Dec 31, 2025 | 1.17B | -39.96% |
| Dec 31, 2024 | 1.94B | 23.18% |
| Dec 29, 2023 | 1.58B | 10.20% |
| Dec 30, 2022 | 1.43B | -8.67% |
| Dec 31, 2021 | 1.57B | 96.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coral Laboratories | 1.51B |
| Lactose (India) | 1.27B |
| Parnax Lab | 1.22B |
| Sotac Pharmaceuticals | 1.11B |
| Concord Drugs | 999.19M |
| Mercury Laboratories | 939.60M |
| Source Natural Foods and Herbal Supplements | 895.06M |
| Mangalam Drugs & Organics | 821.80M |